JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Surgery for Bell's palsy.

Electroneuronographic study of the spontaneous course of Bell's palsy shows that chance of a satisfactory spontaneous return of facial function is reduced by 50% when 95% or more maximal degeneration is reached within two weeks of onset. For this reason immediate surgical decompression (including the meatal foramen) was performed on 14 patients with 90% or more degeneration within three weeks of palsy onset. These patients and 13 who refused treatment under similar conditions were reviewed one to three years later by three physicians familial with facial nerve problems. Results show that to obtain satisfactory (80% to 100%) return of facial movements in all cases of Bell's palsy, surgical decompression should be performed within 24 hours when degeneration reaches 90% to 94% within one to 21 days after onset. By using these guidelines, the number of unnecessary operations will be kept under 16%.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app